Article Text

P205 Admission trends and outcomes of individuals with bronchiectasis admitted to adult general critical care units in England, Wales and Northern Ireland
  1. V Navaratnam1,
  2. C Muirhead2,
  3. RB Hubbard1,
  4. A De Soyza3
  1. 1Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
  2. 2Institute of Health and Society, Newcastle University, Newcastle, UK
  3. 3Institute of Cellular Medicine, Newcastle University & Sir William Leech Centre, Newcastle, UK


Introduction Whilst studies suggest increasing incidence and mortality from bronchiectasis in UK, there are sparse data on outcomes of individuals with bronchiectasis admitted to intensive care (ICU). We investigated trends in bronchiectasis admissions to ICU and estimated outcomes in patients with bronchiectasis admitted to ICU compared to a better studied group, i.e. Chronic Obstructive Pulmonary Disease (COPD).

Methods We used data from the Intensive Care National Audit and Research Centre (ICNARC), a database of patient outcomes from adult critical care units across England, Wales and Northern Ireland. 95% of adult critical care units contribute data to ICNARC which includes information from 1.5 million individuals. Admissions from bronchiectasis and COPD from 1/1/2009 to 31/12/2013 were extracted. Bronchiectasis admissions included patients whose primary or secondary reason for admission was exacerbation of bronchiectasis, excluding people with cystic fibrosis. COPD admissions were those whose primary or secondary reason for admission was either COPD with acute lower respiratory infection; or COPD with acute exacerbation. Patients with COPD-bronchiectasis overlap were excluded. ICU mortality was defined as status on leaving ICU.

Results There were 614,352 admissions across 219 critical care units during the study period, 536 (0.1%) of which were from bronchiectasis and 19,754 (3.2%) from COPD. Bronchiectasis admissions increased from 74 in 2009 to 121 in 2013, equating to a crude annual increase of 8% (95% Confidence Interval [CI] 2 to 15%; p = 0.01) (see Table 1). The mean age increased from 56.6 (standard deviation [SD] 18) to 65.8 years (SD 15.2; p = 0.042) whilst ICU mortality did not change (27.0% vs 28.9%; p = 0.83). The unadjusted yearly increase in COPD admissions was 1% (95% CI: 0.3% to 2%; p = 0.012). The mean age in COPD patients remained static (67.5 years [SD 10.6] vs. 67.9 years [SD 10.6]; p = 0.16), but ICU mortality decreased (20.5% vs. 18.0%; p = 0.005). ICU mortality in people with bronchiectasis over 70 (n = 219) was higher compared to those under 70 (31.1% vs. 18.3%; p < 0.001) despite having similar mean APACHE II acute physiology scores.

Abstract P205 Table 1

Crude admission rates, Poisson regression modelling of admissions, mortality and median ICU length of stay in people with Bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD)

Conclusion Bronchiectasis admissions to ICU are increasing, and ICU mortality for is higher bronchiectasis compared to COPD, particularly in individuals above 70 years of age.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.